MedTrace Logo

Retorna Facial Cream in the Treatment of Facial Wrinkles

NCT00978887 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2010-05-18

No results posted yet for this study

Summary

The purpose of the study is to assess the efficacy of Retorna facial cream usage in the reduction or total correction of facial wrinkles. The duration of this double-blind placebo controlled phase 3 clinical trial will be 4 weeks. The estimated number of women to be recruited and randomized for the study is 148. Occurrence of adverse effects will also be evaluated.

Conditions

  • Facial Wrinkles

Interventions

OTHER

Retorna

Dosage commensurate with surface to be treated, Retorna facial cream (Topical use), twice a day, for 4 weeks.

OTHER

Placebo

Dosage commensurate with surface to be treated, Placebo facial cream (Topical use), twice a day, for 4 weeks

Sponsors & Collaborators

  • Catalysis SL

    lead INDUSTRY

Principal Investigators

  • Jose Dominguez Gómez, MD · "Commander Manuel Fajardo Rivero" Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Cuba

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00978887 on ClinicalTrials.gov